![Cui Ling Wu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cui Ling Wu
Ordförande på
Guangzhou Fulengen Co., Ltd.
Profil
Cui Ling Wu currently works at Guangzhou Fulengen Co., Ltd., as Chairman, Guangzhou Bio-tech Pharmaceuticals Center, as Deputy Director from 2001, and Sun Yat-Sen University, as Professor.
Ms. Wu also formerly worked at Daan Gene Co., Ltd., as Vice Chairman from 2003 to 2022 and Guangzhou Wondfo Biotech Co., Ltd., as Chairman-Supervisory Board.
Ms. Wu received her undergraduate degree from Guangdong Pharmaceutical University.
Aktiva positioner av Cui Ling Wu
| Företag | Position | Start |
|---|---|---|
Sun Yat-Sen University
 Sun Yat-Sen University Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | 2010-03-09 |
Guangzhou Bio-tech Pharmaceuticals Center | Företagsledare/Principal | 2001-03-01 |
Guangzhou Fulengen Co., Ltd.
 Guangzhou Fulengen Co., Ltd. Guangzhou Fulengen Co., Ltd. is a biotechnology and life science research company specializing in genome editing tools, gene function research, and molecular biology products. The company is based in Guangzhou, China. The Chinese company develops and promotes a broad portfolio of products, including full-length cDNA and ORF expression clones, recombinant proteins, RNA interference tools (shRNA, miRNA), custom cloning services, and gene editing technologies such as CRISPR-Cas9 and TALEN. Fulengen offers genome editing solutions encompassing Cas9 proteins, sgRNA libraries, stable cell lines, validation systems, and gene knock-in kits, supporting gene editing research workflows. The company also provides miRNA research tools, qPCR reagents and arrays for gene and miRNA expression profiling, viral vector systems for gene delivery, and nucleic acid virus detection kits for pandemic-related research. Fulengen collaborates with international research institutions and biotech companies, contributing to human genome projects and developing protein expression databases. | Ordförande | - |
Tidigare kända positioner av Cui Ling Wu
| Företag | Position | Slut |
|---|---|---|
| DAAN GENE CO., LTD. | Direktör/Styrelseledamot | 2022-05-27 |
| GUANGZHOU WONDFO BIOTECH CO.,LTD | Ordförande | - |
Cui Ling Wus utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
77
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Daan Gene Co., Ltd.
 Daan Gene Co., Ltd. BiotechnologyHealth Technology Manufactures and distributes molecular biology based reagents & medical equipment | Health Technology |
Guangzhou Bio-tech Pharmaceuticals Center | |
Guangzhou Wondfo Biotech Co., Ltd.
 Guangzhou Wondfo Biotech Co., Ltd. BiotechnologyHealth Technology Engages in the manufacture, sale of biochemical reagents, medical products and diagnostic test kits | Health Technology |
Sun Yat-Sen University
Sun Yat-Sen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Guangdong Pharmaceutical University
 Guangdong Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Guangzhou Fulengen Co., Ltd.
Guangzhou Fulengen Co., Ltd. Guangzhou Fulengen Co., Ltd. is a biotechnology and life science research company specializing in genome editing tools, gene function research, and molecular biology products. The company is based in Guangzhou, China. The Chinese company develops and promotes a broad portfolio of products, including full-length cDNA and ORF expression clones, recombinant proteins, RNA interference tools (shRNA, miRNA), custom cloning services, and gene editing technologies such as CRISPR-Cas9 and TALEN. Fulengen offers genome editing solutions encompassing Cas9 proteins, sgRNA libraries, stable cell lines, validation systems, and gene knock-in kits, supporting gene editing research workflows. The company also provides miRNA research tools, qPCR reagents and arrays for gene and miRNA expression profiling, viral vector systems for gene delivery, and nucleic acid virus detection kits for pandemic-related research. Fulengen collaborates with international research institutions and biotech companies, contributing to human genome projects and developing protein expression databases. |
